• Skip to main content
  • Skip to primary sidebar

Tracking Health and Wellness Applications of Brain Science

Spanish
sb-logo-with-brain
  • Resources
    • Monthly eNewsletter
    • Solving the Brain Fitness Puzzle
    • The SharpBrains Guide to Brain Fitness
    • How to evaluate brain training claims
    • Resources at a Glance
  • Brain Teasers
    • Top 25 Brain Teasers & Games for Teens and Adults
    • Brain Teasers for each Cognitive Ability
    • More Mind Teasers & Games for Adults of any Age
  • Virtual Summits
    • 2019 SharpBrains Virtual Summit
    • Speaker Roster
    • Brainnovations Pitch Contest
    • 2017 SharpBrains Virtual Summit
    • 2016 SharpBrains Virtual Summit
    • 2015 SharpBrains Virtual Summit
    • 2014 SharpBrains Virtual Summit
  • Report: Pervasive Neurotechnology
  • Report: Digital Brain Health
  • About
    • Mission & Team
    • Endorsements
    • Public Speaking
    • In the News
    • Contact Us

Problems grow for neuromodulation firm Helius Medical Technologies

February 15, 2019 by SharpBrains

Investor Alert: Kaplan Fox Inves­ti­gates Helius Med­ical Tech­nolo­gies, Inc. (press release):

“NEW YORK, Feb. 7, 2019 /PRNewswire/ — Kaplan Fox & Kil­sheimer LLP has been inves­ti­gat­ing claims on behalf of investors of Helius Med­ical Tech­nologiues, Inc. (“Helius” or the “Com­pa­ny”) (Nas­daq: HSDT).

On Jan­u­ary 22, 2019, after the mar­ket opened, White Dia­mond Research pub­lished an arti­cle on Seek­ing Alpha titled “Helius Med­ical: A Failed Clin­ic Tri­al, Redact­ed Data, And Ques­tion­able Lead­er­ship, Points To An Inef­fec­tive Device.” The arti­cle states that Helius “is a pre-rev­enue, $200M+ mar­ket cap com­pa­ny claim­ing its only prod­uct, the Portable Neu­ro­mod­u­la­tion Stim­u­la­tor (PoNS) device, can treat a type of brain injury by func­tion­al elec­tri­cal stim­u­la­tion of the tongue.”

The article by White Diamond Research:

Helius Med­ical: A Failed Clin­i­cal Tri­al, Redact­ed Data, And Ques­tion­able Lead­er­ship, Points To An Inef­fec­tive Device (Seek­ing Alpha):

Arti­cle summary:

  • “Helius Med­ical is a reverse-merg­er, sin­gle-prod­uct, pre-rev­enue med­ical device com­pa­ny with a unique device that deliv­ers stim­u­la­tion to the tongue to treat a type of brain injury.
  • Evi­dence sug­gests the device is like­ly a place­bo, and pos­i­tive patient results were from the intense phys­i­cal ther­a­py treat­ment, not the device.
  • The founders, which include Mon­tel Williams and the for­mer CEO who is now a fugi­tive, have a his­to­ry of ques­tion­able mar­ket­ing practices.
  • The phase III tri­al missed its pri­ma­ry effec­tive­ness end­point, thus reduc­ing the chances of FDA approval and reim­burse­ment coverage.
  • The fact that Helius has redact­ed impor­tant tri­al info should cause investors con­cern about the poten­tial effec­tive­ness of the device.”

On the FDA’s request for more information re. PoNS device:

Helius Med­ical Tech­nolo­gies, Inc. Pro­vides Update on FDA’s Review of its Request for De Novo Clas­si­fi­ca­tion and 510(k) Clear­ance of the PoNS™ Device (com­pa­ny press release):

“NEWTOWN, Pa., Jan. 25, 2019 (GLOBE NEWSWIRE) — Helius Med­ical Tech­nolo­gies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Com­pa­ny”), a neu­rotech com­pa­ny focused on neu­ro­log­i­cal well­ness, today announced that it has received a request for an addi­tion­al infor­ma­tion (“AI”) let­ter from the U.S. Food and Drug Admin­is­tra­tion (the “FDA”) relat­ed to the Company’s request for De Novo clas­si­fi­ca­tion and 510(k) clear­ance of the Portable Neu­ro­mod­u­la­tion Stim­u­la­tor (PoNS™) device

Dur­ing the sub­stan­tive review phase of a request for De Novo clas­si­fi­ca­tion and 510(k) clear­ance, FDA may request addi­tion­al infor­ma­tion in order to obtain infor­ma­tion nec­es­sary for the agency to con­tin­ue or com­plete its review and, in such instances, places its review on hold until the request­ed infor­ma­tion is submitted.

“We have enjoyed a good rela­tion­ship with FDA in the devel­op­ment and review of our file.  We believe we have the data and infor­ma­tion to address FDA’s ques­tions and we look for­ward to sub­mit­ting our response to enable FDA to resume its review process as expe­di­tious­ly as pos­si­ble,” said Philippe Deschamps, Helius’ Chief Exec­u­tive Offi­cer.  “We will con­tin­ue to work towards secur­ing clear­ance of PoNS.”

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: FDA, Helius Medical, Helius Medical Technologies, PoNS, Portable Neuromodulation Stimulator

Primary Sidebar

Top Articles on Brain Health and Neuroplasticity

  1. Can you grow your hippocampus? Yes. Here’s how, and why it matters
  2. How learning changes your brain
  3. To harness neuroplasticity, start with enthusiasm
  4. Three ways to protect your mental health during –and after– COVID-19
  5. Why you turn down the radio when you're lost
  6. Solving the Brain Fitness Puzzle Is the Key to Self-Empowered Aging
  7. Ten neu­rotech­nolo­gies about to trans­form brain enhance­ment & health
  8. Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
  9. What Educators and Parents Should Know About Neuroplasticity and Dance
  10. The Ten Habits of Highly Effective Brains
  11. Six tips to build resilience and prevent brain-damaging stress
  12. Can brain training work? Yes, if it meets these 5 conditions
  13. What are cognitive abilities and how to boost them?
  14. Eight Tips To Remember What You Read
  15. Twenty Must-Know Facts to Harness Neuroplasticity and Improve Brain Health

Top 10 Brain Teasers and Illusions

  1. You think you know the colors? Try the Stroop Test
  2. Check out this brief attention experiment
  3. Test your stress level
  4. Guess: Are there more brain connections or leaves in the Amazon?
  5. Quick brain teasers to flex two key men­tal mus­cles
  6. Count the Fs in this sentence
  7. Can you iden­tify Apple’s logo?
  8. Ten classic optical illu­sions to trick your mind
  9. What do you see?
  10. Fun Mental Rotation challenge
  • Check our Top 25 Brain Teasers, Games and Illusions

Join 12,620 readers exploring, at no cost, the latest in neuroplasticity and brain health.

By subscribing you agree to receive our free, monthly eNewsletter. We don't rent or sell emails collected, and you may unsubscribe at any time.

IMPORTANT: Please check your inbox or spam folder in a couple minutes and confirm your subscription.

Get In Touch!

Contact Us

660 4th Street, Suite 205,
San Francisco, CA 94107 USA

About Us

SharpBrains is an independent market research firm tracking health and performance applications of brain science. We prepare general and tailored market reports, publish consumer guides, produce an annual global and virtual conference, and provide strategic advisory services.

© 2022 SharpBrains. All Rights Reserved - Privacy Policy